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Animal Models of Atopic Dermatitis
Haoli Jin1,2, Rui He1,2, Michiko Oyoshi1,2 and Raif S. Geha1
Atopic dermatitis (AD) is characterized by allergic skin inflammation. A hallmark of AD is dry itchy skin due, at
least in part, to defects in skin genes that are important for maintaining barrier function. The pathogenesis of
AD remains incompletely understood. Since the description of the Nc/Nga mouse as a spontaneously occurring
model of AD, a number of other mouse models of AD have been developed. They can be categorized into three
groups: (1) models induced by epicutaneous application of sensitizers; (2) transgenic mice that either
overexpress or lack selective molecules; (3) mice that spontaneously develop AD-like skin lesions. These
models have resulted in a better understanding of the pathogenesis of AD. This review discusses these models
and emphasizes the role of mechanical skin injury and skin barrier dysfunction in eliciting allergic skin
inflammation.
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Introduction
Atopic dermatitis (AD) is an increas-
ingly common pruritic inflammatory
skin disorder that affects at least 15%
of children and is characterized by
cutaneous hyperreactivity to environ-
mental triggers (Geha, 2003; Leung and
Bieber, 2003; Novak et al., 2003) The
diagnosis of AD is based on clinical
presentation of skin erythematous pla-
ques, eruption, and/or lichenification
typically in flexural areas accompanied
by intense pruritus and cutaneous
hypersensitivity. The skin lesions are
associated with one or more typical
atopic signs such as palmar hyperli-
nearity and infraorbital fold. Pathologi-
cal examination reveals spongiosis,
hyperkeratosis, and parakeratosis in
acute lesions and marked epidermal
hyperplasia, acanthosis, and perivascu-
lar accumulation of lymphocytes and
mast cells in chronic lesions. Most AD
patients have a personal or family history
of allergies or asthma. Infants with AD
have an increased tendency to develop
asthma and allergic rhinitis later in life, a
phenomenon known as the atopic
march (Spergel and Paller, 2003).
AD has a complex etiology that
involves abnormal immunological and
inflammatory pathways that include
defective skin barrier, exposure to
environmental agents, and neuropsy-
chological factors (Fartasch, 1997; Pas-
tore et al., 1997; Trautmann et al.,
2000; Geha, 2003; Leung and Bieber,
2003; Novak et al., 2003; Howell
et al., 2004). Approximately 70–80%
of AD patients present with the ‘‘ex-
trinsic’’ form of AD. They have ele-
vated serum IgE levels with IgE
antibodies to environmental and/or
food allergens. The remaining 20–30%
present with the ‘‘intrinsic’’ form of AD
and have low serum IgE levels with no
evidence of IgE antibodies (Leung et al.,
2004). However, a number of these
individuals develop evidence of aller-
gic IgE-mediated sensitization later in
life.
A hallmark of AD is dry itchy skin. It
is believed that this is due to defects in
skin genes that are important for main-
taining skin barrier function and turgid-
ity. In addition, genes that promote
pruritus, for example, IL-31 or a Th2
response to allergens, are likely to also
contribute to the pathogenesis of AD.
Recently, up to 15% of patients with
AD were found to have mutations in
the epidermally expressed filaggrin
gene, which is important for skin
barrier function and turgidity (Palmer
et al., 2006; Morar et al., 2007;
Nomura et al., 2007). Intense pruritus
and the resulting scratching cause
mechanical skin injury that leads to
cytokine and chemokine release in the
skin, which in return causes a further
increase in skin permeability that
further promotes entry of allergens in
the skin (Homey et al., 2006). Epicuta-
neous (EC) sensitization to allergens,
which requires mobilization of antigen-
laden skin dendritic cells (DCs) to
draining lymph nodes (DLN), is be-
lieved to play an important role in the
pathogenesis of the disease. This is
supported by the observation that
application of allergen to the abraded
uninvolved skin of patients with AD
provokes an eczematous rash with
eosinophilic infiltration (Mitchell
et al., 1982).
Acute AD skin lesions exhibit Th2-
dominant inflammation characterized
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by dermal infiltration of CD4þ T cells
and eosinophils with the deposition of
eosinophil products and increased skin
expression of Th2 cytokines. Subse-
quently, the chronic phase demon-
strates a local Th1 IFN-g response
and tissue remodeling with increased
deposition of collagen and dermal
thickening. There are also increased
numbers of mast cells, but virtually
no accumulation of neutrophils. IgE
receptor-bearing DCs, both myeloid
and plasmacytoid, also accumulate in
the lesion and may be instrumental in
the perpetuation of AD (Novak et al.,
2004; Novak and Bieber, 2005).
DCs are essential for the generation
of an immune response and hence play
a critical role in the pathophysiology of
AD. In the skin, there are two main
types of immature DCs, namely Lan-
gerhans cells in the epidermis and
interstitial (dermal) DCs in the dermis.
Langerhans cells form a DC network in
the epidermis where they sample anti-
gens that get through the skin barrier of
stratum corneum (SC). Antigens that
reach the interstitial spaces are taken
up by interstitial (dermal) DCs. Follow-
ing antigen uptake and in the presence
of a danger signal generated by micro-
bial antigens that include normal flora
and/or mechanical injury with its
release of mediators such as IL-1 and
tumor necrosis factor-a, immature DCs
acquire the phenotype of functional
antigen-presenting cells (APC). They
upregulate the expression of major
histocompatibility complex class II
molecules and of key co-stimulatory
molecules such as CD80 and CD86,
reduce their capacity to capture anti-
gen, and express chemokine receptors,
particularly CCR7, the receptor for the
chemokines CCL19 and CCL21 ex-
pressed in DLNs. The expression of
CCR7 allows skin DCs to migrate
toward DLN where they present anti-
genic peptides to naive T cells that
continuously circulate through the
DLN. Interaction between antigen-la-
den DCs and antigen-specific T cells
leads to T-cell proliferation and differ-
entiation. Differentiation of CD4þ T
cells leads to the generation of Th1
cells that secrete IFN-g, Th2 cells that
secrete IL-4, IL-5, and IL-13, or Th17
cells that secrete IL-17 and IL-22. DCs
play a critical role in the polarization of
T cells into Th1, Th2, or Th17 cells
depending on their specific expression
of cytokines and co-stimulatory mole-
cules and the influence of the indivi-
dual tissue milieu from which they
originate. After EC sensitization, loss
of protection by the skin barrier in-
creases the exposure of Langerhans
cells and dermal DCs to environmental
antigens. Cytokines released by resi-
dent skin cells are likely to play an
important role in influencing the ability
of DCs to polarize T cells. Examples of
these cytokines are thymic stromal
lymphopoietin (TSLP) and IL-6. TSLP
is an IL-7-like cytokine produced by
keratinocytes, and is highly expressed
in AD skin lesions. Evidence suggests
that TSLP polarizes DCs to promote an
inflammatory Th2 response character-
ized by high-production tumor necrosis
factor-a with little production of IL-10
(Liu, 2007). Transforming growth fac-
tor-b and IL-6 expression is upregulated
in skin after mechanical injury, which
may be important in polarizing DCs to
promote a Th17 response to EC sensi-
tization injury (He et al., 2007; our
unpublished observations).
Our understanding of human dis-
eases has been enormously expanded
by the use of animal models, because
they allow in-depth investigation of
pathogenesis and provide invaluable
tools for diagnostic and pharmaceutical
purposes. Because AD is a common
disease for which there is no satisfac-
tory therapy, understanding AD
through the study of animal models is
a pressing need. Although species other
than mouse, for example, dogs and
guinea pigs, can develop AD-like
lesions, mouse models are primarily
used because of the ease of manipula-
tion, low cost, and most importantly
the availability of genetically manipu-
lated strains. Since the description of
the Nc/Nga mouse as the first sponta-
neously occurring model of AD in 1997
(Matsuda et al., 1997), a number of
mouse models have been developed.
These models can be categorized into
three groups: (1) models induced by EC
application of sensitizers; (2) transgenic
mice that either overexpress or lack
selective molecules; (3) mice that
spontaneously develop AD-like skin
lesions. These models display many
features of human AD, and their study
has resulted in a better understanding
of the pathogenesis of this disease.
AD models induced by EC sensitization
An animal model of AD induced by
skin injury and EC sensitization with
allergen. Our laboratory has developed
a mouse model of AD induced by
repeated EC sensitization of tape-
stripped skin with ovalbumin (OVA)
(Spergel et al., 1998). This model
operates in all five strains of mice
tested to date including BALB/c and
C57BL/6 mouse strains (Spergel et al.,
1999). The back skin of mice is shaved
and tape stripped six times with 3M
tape, mimicking skin injury inflicted by
scratching in patients with AD. A
100mg portion of OVA in 100ml of
normal saline or 100ml of normal
saline is placed on a 11 cm patch
of sterile gauze, which is secured to the
skin with a transparent bioocclusive
dressing. This ensures that the antigen
is not accessible to licking. Each mouse
has a total of three 1 week exposures to
the patch at the same site; exposures are
separated by 2 week intervals (Figure 1).
EC-sensitized mice develop in-
creased scratching behavior, and their
skin develops lesions characterized by
epidermal and dermal thickening, in-
filtration of CD4þ T cell and eosino-
phils (Figure 2a), and upregulated
expression of the Th2 cytokines IL-4,
IL-5, and IL-13 (Figure 2b), with little or
no change in the expression IFN-g.
There is enhanced expression of
eotaxin and thymus and activation-
regulation chemokine, the chemokines
that attract CC chemokine receptor 3
(CCR3)þ eosinophils and skin-homing
CCR4þ CD4þ T cells, respectively.
There is also increased deposition of
collagen. Systemically, serum OVA-
specific IgG1, IgE, and IgG2a are
elevated, and splenocytes from OVA-
sensitized mice produce increased level
of IL-4, IL-5, IL-13, and IFN-g in
response to OVA re-stimulation (Spergel
et al., 1998). The fact that antigen-
specific IFN-g-producing cells are pre-
sent in the spleen, with no detectable
upregulation of IFN-g expression in
sensitized skin sites, suggests that
local factors at the site of sensitization
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promote selectively the activation of
Th2 cells. In this respect, TSLP promotes
the secretion of Th2 cytokines with
no detectable effect on the secretion of
Th1 cytokines by TCR-OVA transgenic
T cells stimulated in vitro with OVA
peptide (R He, unpublished observa-
tions). In addition, OVA-sensitized mice
develop increased airway hyperrespon-
siveness following inhalation challenge
with OVA, a feature that parallels the
occurrence of asthma in a majority of
patients with AD. (Spergel et al., 1998).
Decreasing the cycles of sensitization
from three to two or compressing the
duration of the sensitization protocol by
decreasing the interval between the
cycles of sensitization leads to sub-
optimal development of allergic skin
inflammation. The requirement for a
7-week protocol of EC sensitization,
although cumbersome, appears to
mimic the exacerbation of AD over
time. Withdrawal of antigen sensitiza-
tion at the end of the 7-week protocol
results in decreased skin inflammation
with IL-4 mRNA levels returning to
baseline within 7–10 days, whereas
IL-13 mRNA levels decrease over a
longer period of time.
We have used this mouse model to
determine the critical cellular players
involved in allergic skin inflammation.
Using RAG2/ mice, which lack both
T and B cells, B-cell-deficient IgH/
mice, TCRb/ mice, and CD40-
deficient mice, we demonstrated that
TCRabþ T cells, but not gdþ T cells, B
cells, or CD40L–CD40 interactions are
critical for skin inflammation and the
Th2 response in AD (Woodward et al.,
2001). The study of mast cell-deficient
mice indicated that mast cells are
not important for the development of
Th2-mediated skin inflammation; how-
ever, they regulate IFN expression in
the skin (Alenius et al., 2002) This is
important given the role of IFN-g in
upregulating Fas expression on kerati-
nocytes, thus targeting them for killing
by activated FasLþ T cells (Trautmann
et al., 2000) and given the role of
IgE-mediated reactions in exacerbating
AD (Milgrom, 2002). A recent study
showed that iNKT cells are not required
for allergic skin inflammation in this
model. Skin infiltration by eosinophils
and CD4þ cells and expression of
mRNA encoding IL-4 and IL-13 in
OVA-sensitized skin were similar in
wild-type (WT) and CD1d/ mice. No
significant increase in iNKT cells was
detectable in epicutaneously sensitized
skin. In contrast, iNKT cells were found
in the bronchoalveolar lavage fluid from
OVA-challenged epicutaneously sensi-
tized WT mice, but not in CD1d/
mice, and EC-sensitized CD1d/ mice
had decreased expression of IL-4, IL-5,
and IL-13 mRNA in the lung and
impaired airway hyperresponsiveness
in response to airway challenge with
OVA (ElKhal et al., 2006).
We have used the EC sensitization
model to examine the role of a number
of molecules, cytokines, chemokines,
and molecules of innate immunity in
the development of allergic skin
inflammation elicited by EC exposure
to allergens (Spergel et al., 1999; Ma
et al., 2002; Kawamoto et al., 2004;
Laouini et al., 2005). Both the Th2
cytokines IL-4 and IL-5 and the Th1
cytokine IFN-g play important roles in
the inflammation and hypertrophy of
the skin in AD. Eosinophils are virtually
absent in OVA-sensitized skin sites of
IL-5/ mice. OVA-sensitized skin sites
of IL-4/ mice have increased inflam-
matory cells but decreased eosinophils,
and those of IFN-g/ mice have
decreased thickening of the dermal
layer (Spergel et al., 1999).
IL-10 plays an important role in
the Th2 response to antigen and in the
development of skin eosinophilia in
our model (Laouini et al., 2003a). Skin
infiltration by eosinophils and expres-
sion of eotaxin, IL-4, and IL-5 mRNA in
OVA-sensitized skin sites were all
Shaving and tape striping
Day 1 7 21 28 42 49 50
Sensitization Sensitization Sensitization
Skin :H&E, IHC,  
  RNA for RT-PCR
Serum anti- OVA Abs
Spleen cytokines
AHR
Patching with
OVA 100 µg per 100 µl in saline
Figure 1. EC sensitization protocol. Mice were sensitized with ovalbumin (OVA) (100 mg) or saline
applied in 100 ml to a sterile patch. The patch was placed for a 1-week period and then removed.
Two weeks later, an identical patch was reapplied to the same skin site. Each mouse had a total of
three 1 week exposures to patch separated from each other by 2 week intervals. All experiments
were performed at the end of the third sensitization.
Saline sensitization OVA sensitization
Epid
Dermis
Figure 2. Histological features of ovalbumin (OVA) and saline-sensitized skin sites in BALB/c mice. Skin
sections were stained with hematoxylin and eosin (H&E) and examined at original magnifications
200 and 400. There is marked hyperplasia of the epidermis, a dermal infiltrate, and mild spongiosis.
The cellular infiltrate consists of neutrophils, eosinophils, and lymphocytes. Further magnification
in the inset (bold-bordered box) shows the presence of the multiple eosinophils.
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severely diminished in IL-10/ mice.
After in vitro re-stimulation with OVA,
splenocytes from EC-sensitized IL-10/
mice secreted significantly less IL-4, but
significantly more IFN-g than spleno-
cytes from WT controls. IL-10/ APCs
skewed the in vitro response of OVA
TCR transgenic T cells toward Th1.
Examination of the Th response of
WT and IL-10/ mice immunized
with OVA-pulsed WT or IL-10/ DCs
revealed that both DCs and T cells
participate in IL-10-mediated skewing
of the Th2 response in vivo. Current
experiments are addressing the hypo-
thesis that IL-10 released by keratino-
cytes after mechanical injury might
promote the Th2 response to EC sensi-
tization through polarizing skin DCs
to support Th2 differentiation.
CCR3 is expressed by eosinophils,
mast cells, and Th2 cells. Recruitment
of eosinophils to OVA-sensitized skin
was severely impaired in CCR3/
mice. These mice also have impaired
recruitment of eosinophils in their
lung parenchyma and bronchoalveolar
lavage fluid, and fail to develop airway
hyperresponsiveness to methacholine
following antigen inhalation. These
results suggest that CCR3 plays an
essential role in eosinophil recruitment
to the skin and the lung and in the
development of airway hyperrespon-
siveness (Ma et al., 2002). Skin-homing
T cells express the chemokine receptor
CCR4. The CCR4 ligand thymus and
activation-regulation chemokine is
highly expressed in most AD skin
lesions. Experiments with CCR4/
mice have revealed decreased CD4þ
cell infiltration in OVA-sensitized sites
as well as decreased expression of IL-4
and IL-13 mRNA levels (our unpub-
lished observations). CCR10 is also
expressed on a subset of skin-homing
cells. Anti-CCR10 was reported to
inhibit skin inflammation in response
to EC sensitization with OVA (Homey
et al., 2002). However, we have found
that CCR10/ mice develop normal
allergic skin inflammation (our unpub-
lished observations).
Recently, we found that EC sensiti-
zation with OVA drives the generation
of IL-17-producing T cells in DLNs and
spleen and in a local and systemic
Th17 response (He et al., 2007). OVA
inhalation by EC-sensitized mice in-
duced IL-17 and CXCL2 expression and
neutrophil influx in the lung along with
bronchial hyperreactivity, which were
reversed by IL-17 blockade. This is in
contrast to the eosinophil-dominated
response of intraperitoneally immu-
nized mice to airway challenge.
Although IL-17 was expressed in
EC-sensitized skin, there was little
expression of CXCL2 and little infiltra-
tion of neutrophils at EC-sensitized skin
sites. However, mechanical injury
upregulated the expression of IL-6 and
IL-23 in skin. IL-6, like transforming
growth factor-b, is an inducer of Th17
cells (Veldhoen et al., 2006), whereas
IL-23 promotes the growth of these
cells (Langrish et al., 2005). DCs
trafficking from skin to lymph nodes
expressed more IL-23 and induced
more IL-17 secretion by naive T cells
than splenic DCs. This was inhibited by
neutralizing IL-23 in vitro and by
intradermal injection of anti-transform-
ing growth factor-b-neutralizing anti-
body in vivo. These findings suggest
that initial cutaneous exposure to anti-
gens in patients with AD may selec-
tively induce the generation of IL-17
producing cells. Upon antigen inhala-
tion, these cells are recruited to the
lungs where they are activated to
secrete IL-17, which drives a neutro-
phil-rich inflammation in the airways.
These findings should prompt a search
for airway and lung neutrophils in
AD patients who develop asthma in
response to inhalation of EC sensitizers.
This could have important therapeutic
implications.
We have identified a number of
negative regulators of allergic skin
inflammation in our model. C3aR/
mice exhibited an exaggerated Th2
response to EC sensitization with
OVA. Presentation of OVA peptide by
C3aR/ APCs caused significantly
more IL-4 and IL-5 secretion by T cells
from TCR-OVA DO11.10 transgenic
mice compared with the presentation
by WT APCs. C3a inhibited the ability
of splenocytes, but not of highly
purified T cells, to secrete Th2 cyto-
kines in response to TCR ligation. This
inhibition was mediated by IL-12 se-
creted by APCs in response to C3a.
These results suggest that C3a–C3aR
interactions inhibit the ability of APCs
to drive Th2 cell differentiation in
response to epicutaneously introduced
antigen (Kawamoto et al., 2004). Cyclo-
oxygenase 2 was also shown to limit
the Th2 response to EC sensitization.
Infiltration by eosinophils and expres-
sion of IL-4 mRNA in OVA-sensitized
skin sites, OVA-specific IgE and IgG1
antibody responses, and IL-4 secretion
by splenocytes after OVA re-stimula-
tion were all significantly increased in
EC-sensitized mice that received NS-
398, a cyclooxygenase 2 inhibitor. In
contrast, OVA-specific IgG2a antibody
response and IFN-g secretion by sple-
nocytes after OVA re-stimulation were
significantly decreased in these mice.
Cyclooxygenase 2-deficient mice also
exhibited an enhanced systemic Th2
response to EC sensitization. These
findings are important, as they suggest
that cyclooxygenase inhibitors may
worsen allergic skin inflammation in
patients with AD (Laouini et al., 2005).
The complement component C3 is
synthesized by keratinocytes and is
activated after skin injury. Skin infiltra-
tion by eosinophils and the expression
of Th2 cytokines in OVA-sensitized
skin sites were impaired in C3/ mice.
Splenocytes from epicutaneously
sensitized C3/ mice secreted less
IL-4, IL-5, IL-13, and IFN-g in response
to OVA re-stimulation than spleno-
cytes from WT control animals. C3/
mice also had impaired IgG1, IgG2a,
and IgE antibody responses after both
EC immunizations. These results sug-
gest that C3 plays an important role in
both the Th1 and Th2 response to
antigen in AD (Yalcindag et al.,
2006). The opposing consequence of
C3aR and C3 deficiency in our model
suggests that C3 degradation products
other than C3a may promote allergic
skin inflammation. C3b is a good
candidate, as its receptor is expressed
on DCs.
Mechanical injury is critical in our
model, because application of OVA to
the skin of hairless mice does not result
in the development of an immune
response to OVA. Recently, we have
begun to test the hypothesis that
mechanical injury not only allows the
breaching of the skin barrier and the
entry of antigen which is then captured
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by skin DCs, but also releases media-
tors that may play critical roles in
polarizing the DCs to drive the differ-
entiation of Th2 cells in DLN. Gene
array analysis of mouse skin 12 hours
after skin injury reveals the upregula-
tion of a number of cytokines with a
remarkable increase in IL-6, a cytokine
which is important for both Th2 and
Th17 differentiation (our unpublished
data). There is also an increase in IL-23,
IL-1, and IL-10 gene expression. In
addition, a number of chemokine
genes, as well as genes for metallopro-
teinases and kallikreins, are highly
upregulated. These injury-induced mo-
lecules are likely to play important
roles in determining the polarity of the
immune response to EC sensitization.
In this regard, neutralization of IL-23
blocks the Th17 response (Langrish
et al., 2005; Chen et al., 2006), and
blocking IL-10 impairs the Th2 re-
sponse (Oh et al., 2002). We are using
FITC painting of shaved versus shaved
and tape-stripped skin to track DCs that
have emigrated from skin to DLN to test
the hypothesis that this polarization
effect is exerted at the level of the
DCs that carry antigen from skin to
DLN (Figure 3). Preliminary data sug-
gest that FITChi DCs isolated from DLN
of shaved tape-stripped skin induce
significantly more Th2 cytokine secre-
tion in TCR-OVA transgenic D011.10
cells than FITChi DCs isolated from
DLN of shaved skin that has not been
tape stripped. Comparative analysis of
the genes differentially expressed by
these two populations of DCs should
help elucidate the nature of the ‘‘dan-
ger signal’’ elicited by mechanical skin
injury that results in the generation of a
predominantly Th2 response to EC
sensitization.
AD model induced by EC application
of house dust mite allergen. Clinical
studies have provided evidence that
house dust mite allergen is associated
with human AD (Kimura et al., 1998).
BALB/c mice subjected to EC applica-
tion of the recombinant mite allergen
Der p8 exhibited features of dermatitis
with epidermal hyperplasia and spon-
giosis, skin infiltration with CD4þ and
CD8þ cells, and a skewed Th2 re-
sponse locally and systemically (Huang
et al., 2003). These findings are similar
to those observed with EC sensitization
with OVA. Immunohistochemistry re-
vealed the expression of neuropeptides
only in Der p8-treated skin. Nerve
fibers were observed in close proximity
of mast cells in the dermis. These
findings may suggest an interaction
between the nervous and immune
systems in the skin lesions of AD.
Hapten-induced mouse models of AD.
Haptens such as oxazolone (Ox) and
trinitrochlorobenzene are commonly
used to induce allergic contact derma-
titis and have been thought to evoke
primarily a Th1-dominated response.
However, it has been recently reported
that multiple challenges with Ox or
trinitrochlorobenzene to the skin of
hairless mice over an extended period
cause the skin inflammation to shift
from a typical Th1-dominated delayed-
type hypersensitivity response to a
chronic Th2-dominated inflammatory
response that is similar to human AD
(Matsumoto et al., 2004) (Man et al.,
2008). Indeed, 9–10 challenges with
Ox to hairless mice produced a chronic
Th2-like skin inflammation. The in-
flammation was characterized by der-
mal infiltration of Th2 lymphocytes that
express the PGD2 receptor CRTH2,
mast cells, and eosinophils, increased
expression of IL-4 in the dermis, and
highly elevated IgE levels. Repeated
challenge with Ox led to increased
epidermal hyperplasia and decreased
expression of the skin differentiation
proteins filaggrin, loricrin, and involu-
crin. A skin barrier abnormality be-
came evident and was associated with
decreased SC ceramide content and
hydration, increased transepidermal
water loss and impaired lamellar
body secretion, resulting in reduced
lamellar membranes, as observed in
AD patients. Furthermore, as in human
AD, epidermal serine protease activity
in SC increased and the expression of
two lamellar body-derived antimicro-
bial peptides, CRAMP and mBD3,
declined after Ox challenges, parallel-
ing the decrease of their human homo-
logs in AD skin lesions. These changes
were not observed after a single
challenge with hapten, the classical
way to elicit hapten-delayed hyper-
sensitivity reaction.
Although the hapten repeated sensi-
tization model is not a genetically
driven model, many of its aspects may
be applicable to extrinsic allergen-
driven AD. Indeed, it particularly illus-
trates the notion that once allergen is
introduced via a breach in the barrier,
the resulting allergen-driven inflamma-
tion further damages the skin barrier.
This amplificatory cycle may play an
important role in the perpetuation and
exacerbation of human AD. This model
needs to be compared head to head
with a protein (OVA and house dust
mite) repeated sensitization model.
Because of its reproducibility, predict-
ability, low cost, and relative rapidity,
the hapten repeated sensitization
model could prove useful for evaluat-
ing pathogenic mechanisms and poten-
tial therapies for AD.
Skin
Lymph 
node
Mechanical injury
FITC
Lymph
node DC
DC from
tape-stripped
skin
DC from
painted skin
FITC painted
on tape
stripped skin
FITC painted
on shaved
skin
Isolate CD11c+ cells from skin draining lymph node, then sort FITC+ cells
Culture FITC+ DC with naïve DO.10.11 TCR-OVA CD4+ T cells
Stimulate with OVA 323–339 peptide or OVA
Measure proliferation and cytokine secretion
Figure 3. Scheme for testing the effect of tape stripping on DC polarity.
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Superantigen-induced mouse models of
AD. Staphylococcus aureus colonization
or infection, the most common cause of
AD exacerbates. Of all S. aureus strains
isolated from lesional skin, up to 65%
produce exotoxins with superantigenic
properties. We have shown that applica-
tion of SEB instead of OVA by repeated
EC sensitization to tape-stripped skin
was able to elicit Th2-dominated aller-
gic skin inflammation accompanied by
a systemic Th2 response to the super-
antigen (Laouini et al., 2003b).
Amurine model of AD in mice with food
hypersensitivity. The pathogenic role of
food allergy in a subset of AD patients has
been supported by clinical studies (Samp-
son and McCaskill, 1985). Repeated
intragastric sensitization of C3H/HeJ mice
with cow’s milk or peanut, with cholera
toxin as adjuvant, caused hair loss,
scratching, and chronic relapsing AD-like
skin lesions in up to 35% mice. This was
accompanied by elevated serum levels
of specific IgE and blood eosinophilia
(Li et al., 2001). Our recent findings show
that mice orally sensitized with OVA in
the presence of the adjuvant cholera toxin
develop allergic skin inflammation at skin
sites challenged with OVA (M Oyoshi
et al., unpublished observations). These
results raise the possibility that flare-ups
of AD lesions may occur in orally
sensitized individuals following the intro-
duction of food allergens into the skin.
Genetically engineered mouse models
of AD
IL-4 transgenic mice. Transgenic mice
overexpressing IL-4 in the skin develop
spontaneous pruritus and chronic der-
matitis at the age of 4 months (Chan
et al., 2001). The onset and early
progression of skin inflammation was
found to correlate with the elevation of
IgE and IgG1. The early skin lesions are
characterized by prominent infiltration
of T cells in the epidermis and dermis,
whereas chronic lesions showed T-cell
accumulation in the dermis. The
chronic lesions also showed features of
human AD, including acanthosis of the
epidermis with mild spongiosis, hyper-
keratosis, and dermal eosinophils.
IL-31 transgenic mice. IL-31 is a pre-
viously unidentified cytokine produced
by activated T cells. IL-31 expression is
upregulated in pruritic AD skin lesions
but not in nonpruritic psoriatic skin
inflammation (Dillon et al., 2004). The
expression level of IL-31 is associated
with the magnitude of skin pruritus.
Transgenic mice overexpressing IL-31,
driven by the lymphocyte-specific pro-
moter Lck or by the ubiquitous elonga-
tion factor-1a promoter, exhibited signs
of dermatitis at the age of 2 months,
including pruritus, mild-to-moderate
hair loss, and considerable thickening
of ear skin. These symptoms progressed
with age, and reached a peak at the age
of 6 months. Histological examination
of skin lesions revealed hyperkeratosis,
acanthosis, inflammatory cell infiltra-
tion, and an increase in mast cells,
which resemble the skin lesions of
human AD. However, these mice ex-
hibited normal serum concentrations of
IgE. The evaluation of local or systemic
Th2 response was not reported.
TSLP transgenic mice. TSLP is ex-
pressed primarily by epithelial cells
including epidermal keratinocytes.
TSLP is highly expressed in the skin
lesions of patients with AD, where it is
associated with the activation and
migration of DCs within the dermis
(Soumelis et al., 2002). Mice on BALB/
c background were made to over-
express a tetracycline-inducible, skin-
specific TSLP under the control of the
keratin 5 promoter (Yoo et al., 2005).
Skin erythema occurred atB2–3 weeks
of doxycycline treatment, and pro-
gressed to AD-like changes, including
persistent erythema, mild xerosis, crust-
ing, and erosions at 3–4 weeks. Histo-
logical examination of skin lesions
showed changes similar to those
observed in human AD, including
acanthosis, spongiosis, hyperkeratosis,
and dermal infiltration, characterized
by a predominance of lymphocytes and
macrophages, and an abundance of
mast cells and eosinophils. Skin lesions
of TSLP transgenic mice exhibited a
Th2 cell profile with the upregulation
of IL-4, IL-5, and tumor necrosis factor-
a. These mice also showed elevated
serum levels of IgE and IgG1, and
decreased IgG2a. When crossed with
TCRb/ mice that lack T cells, TSLP
transgenic mice still developed AD-like
skin changes with a dense accumu-
lation of mast cells and eosinophils
in the dermis, suggesting that skin
inflammation in these mice is T-cell
independent.
Caspase-1 and IL-18 transgenic mice.
IL-18 is a unique proinflammatory
cytokine capable of strongly stimulat-
ing both IFN-g and IL-4 production
when it acts on freshly isolated T cells
with IL-12 and IL-2, even in the
absence of T-cell antigen receptor
engagement. In vitro IL-18 in the
presence of IL-3 directly stimulates
basophils and mast cells to produce
IL-4, IL-5, and IL-13 cytokines in an
IgE-independent manner (Nakanishi
et al., 2001). This innate style of T cell
and mast cell activation is one of the
outstanding properties of IL-18. Admin-
istration of IL-18 to normal BALB/c
or C57BL/6 mice induces polyclonal
IgE production in a CD4 T cell-, signal
transducer and activator of transcrip-
tion factor 6 (STAT6)-, and IL-4-depen-
dent manner (Okamura et al., 1995).
IL-18 is expressed in AD skin and
single nucleotide polymorphisms in the
IL-18 gene are associated with AD
(Kim et al., 2007). Similar to IL-1b,
IL-18 is stored as a biologically inactive
precursor in various cell types, includ-
ing macrophages and keratinocytes,
and becomes active after cleavage
with caspase-1 (CASP1). Transgenic
mice overexpressing the human CASP1
precursor gene in epidermal keratino-
cytes under the control of the human
keratin 14 promoter (CASP1 transgenic
mice) showed elevated serum levels
of IgE and IgG1 at the age of 8 weeks,
and mild pruritic dermatitis around the
eyes and ears at the age of 16 weeks
(Yamanaka et al., 2000). Histological
examination showed prominent acan-
thosis, papillomatosis, parakeratosis,
and intracellular edema with dense
infiltration of lymphocytes, neutrophils,
and mast cells, but not eosinophils in
the skin lesion. CASP1 transgenic mice
on STAT6-deficient background still
suffered from chronic dermatitis similar
to that observed in CASP1 transgenic
littermates, but with no detectable IgE
production, suggesting a dispensable
role of IgE in the development of the
AD-like dermatitis in CASP1 transgenic
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mice. A high concentration of mature
IL-18 was found in the serum of the
CASP1 transgenic mice. IL-18-deficient
CASP1Tg evaded the dermatitis,
confirming the critical role of IL-18 in
the CASP1 mouse model of AD and
suggesting that IL-18 causes the skin
changes in the absence of IgE and
STAT6. Because of this and because
in this model, there is no obvious need
for allergen exposure to develop der-
matitis, and it has been proposed that
the CASP1 mouse model may mimic
intrinsic AD in which elevated levels of
serum IL-18 can also be found. Trans-
genic mice overexpressing murine ma-
ture IL-18 under the control of human
K14 promoters exhibited similar skin
changes with delayed disease onset
when compared with CASP1 transgenic
mice (Konishi et al., 2002). IL-1b-
deficient CASP1 and IL-18 transgenic
mice exhibited similar dermatitis but at
a later stage (around 6 months), sug-
gesting a role for IL-1b in accelerating
the dermatitis initiated by IL-18 locally
released in the skin. Both CASP1Tg and
IL-18Tg mice had increased neutrophils
in the spleen and spontaneous devia-
tion of splenic T cells to Th2 and away
from Th1, evident by the increased
production of IL-4 and IL-5 and de-
creased IFN-g production in response
to anti-CD3 stimulation. In addition,
these Tg mice had elevated serum IgG1
as well as IgE levels. Importantly, the
number of skin mast cells, the levels
of histamine in the plasma, and the
frequency of skin scratching behavior
were all elevated in CASP1Tg and
IL-18Tg mice as in human AD.
RelB knockout mice. RelB belongs to
the NF-kB/Rel family of transcription
factors, which play critical roles in
stress-induced, immune, and inflamma-
tory responses. In adult mice, RelB
expression is restricted to lymphoid
tissues. RelB/ mice exhibit hemato-
poietic abnormalities and mixed inflam-
matory cell infiltration in several organs,
including skin (Weih et al., 1997; Barton
et al., 2000). These mice developed
spontaneous dermatitis, hyperkeratosis,
acanthosis, skin infiltration with CD4þ
T cells and eosinophils, and elevated
serum IgE, all features of human AD,
although pruritus was not reported.
When crossed with nur77 transgenic
mice in which the peripheral T cells are
absent, RelB/ mice exhibited an
apparently alleviated dermatitis charac-
terized by reduced epidermal hyper-
plasia and keratinocyte proliferation,
suggesting that skin inflammation in
these mice is T-cell dependent.
Cathepsin E knockout mice. The aspar-
tic proteinase cathepsin E (Cat E) is
localized mainly in the endosomal
structures of APCs and has been
implicated in a variety of immune
responses. Under conventional condi-
tions, Cat E/ mice on C57BL/6 back-
ground developed pruritic and erosive
skin lesions, from which S. aureus. was
identified (Tsukuba et al., 2003). Serum
levels of total IgE were increased
and the secretion of Th2 cytokines by
splenocyte in vitro was also increased,
whereas the production of IFN-g and
IL-2 was normal. Histological examina-
tion showed epidermal hyperplasia and
dermal infiltration with eosinophils,
lymphocytes, and macrophages. The
function of skin DCs in the Cat E/
mice was not reported. Given the recent
findings that cathepsin E differentially
regulated the nature and function of
DCs and macrophages, these mice
could be a good model for studying
the role of APCs in AD pathogenesis.
SC chymotryptic enzyme transgenic
mice. SC chymotryptic enzyme, which
belongs to the kallikrein group of serine
protease, is preferentially expressed in
cornifying epithelia. Its expression is
further increased in chronic lesions of
AD as well as in psoriasis (Ekholm and
Egelrud, 1999). Overexpression of a
human SC chymotryptic enzyme trans-
gene in suprabasal epidermal keratino-
cytes of mice led to the development of
AD-like skin inflammation character-
ized by increased epidermal thickness,
hyperkeratosis, and dermal inflamma-
tion starting at the age of 7–8 weeks or
older (Hansson et al., 2002). Trans-
genic mice showed signs of itching at
the age of 10–11 weeks. The frequency
of scratching increased with age.
The fact that signs of itching occurred
after epidermal thickening suggested
that the pruritus was secondary to the
changes in the skin, rather than a direct
effect of SC chymotryptic enzyme.
Histamine antagonists failed to allevi-
ate the scratching behavior in SSCE
transgenic mice, suggesting that hista-
mine was unlikely the cause of pruritus
in these mice.
Apolipoprotein C1 transgenic mice.
APOC1 is an apolipoprotein involved
in lipoprotein metabolism (Jong et al.,
1998) In healthy individuals, the pro-
tein is predominantly expressed in
liver, skin, and brain tissue with macro-
phages and keratinocytes as major cell
types. The protein is highly conserved
and a high degree of homology exists
between APOC1 in mice and humans.
Mice transgenic for human apolipopro-
tein C1 (APOC1Tg mice) in liver and
skin have increased levels of free fatty
acids, cholesterol, and triglycerides,
but show a complete absence of sub-
cutaneous fat and atrophic sebaceous
glands. The composition of the SC is
dependent on lipid homeostasis.
APOC1Tg mice not only have dis-
turbed serum levels of lipids but they
also spontaneously develop with age
severe dermatitis with moderate epi-
dermal hyperplasia, and hyperkeratosis
and parakeratosis, scaling, lichenifica-
tion, excoriations, and pruritus. Histo-
logical analysis shows increased
epidermal thickening and spongiosis
in conjunction with elevated numbers
of inflammatory cells, including eosi-
nophils, neutrophils, mast cells, macro-
phages, and CD4þ T cells in the
dermis (Nagelkerken et al., 2007). In
addition, the mice have increased
serum levels of IgE and show abundant
numbers of mast cells in the dermis.
Importantly, they display a disturbed
skin barrier function, evident from
increased transepidermal water loss.
Partial inhibition of disease could be
achieved by restoration of the skin
barrier function with topical applica-
tion of a lipophilic ointment. Further-
more, the development of dermatitis
in these mice was suppressed by
corticosteroid treatment. These findings
underscore the role of skin barrier
integrity in the pathogenesis of AD.
Spontaneous mouse models of AD
The Nc/Nga mouse. Nc/Nga mice,
an inbred mouse strain, was the first
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mouse model of AD reported by
Matsuda et al. (1997). Skin changes
develop spontaneously in Nc/Nga mice
secondary to the exposure to various
environmental aeroallergens and clo-
sely mimic human AD. AD-like disease
only develops when mice are kept
under conventional conditions, parti-
cularly when the mice are infected with
mites, but not under sun protection
factor conditions. Scratching behavior,
the first sign of the skin changes, occurs
at 6–8 weeks, and is followed by
rapidly developing erythematous, ero-
sive lesions with edema, and hemor-
rhages on the face, ears, neck, and
back. Histological examination shows
dermal infiltration with eosinophils and
mononuclear cells before the appear-
ance of clinical skin manifestations.
Hyperparakeratosis, hyperplasia, and
spongiosis are observed in the skin
lesions at the age of 17 weeks. Nc/
Nga mice display mutations on chro-
mosome 9, which is linked to increased
IgE production as well as increased Th2
responses. Constitutive tyrosine phos-
phorylation of Janus kinase 3, a tyr-
osine kinase responsible for IL-4R-
mediated signaling, is thought to be
involved in the enhanced sensitivity of
B cells to IL-4, leading to the elevation
of total IgE levels (Matsumoto et al.,
1999). Along with the skin changes,
Nc/Nga mice exhibit preferential Th
differentiation toward Th2 cells in
the spleen, dense accumulation of
eosinophils and mast cells in skin
lesions, and an increased serum level
of total IgE (Vestergaard et al., 1999;
Kohara et al., 2001). Moreover,
the Th2-specific chemokines, thymus
and activation-regulation chemokine,
and monocyte-derived chemotactic
cytokine, and their receptor, CCR4,
have been reported to be highly
expressed in the lesions of the Nc/Nga
mouse as in AD skin lesions (Vester-
gaard et al., 1999; Kohara et al., 2001).
These findings strongly suggest the
involvement of Th2 cells in the deve-
lopment of AD-like skin lesions in the
Nc/Nga mouse.
However, STAT6-deficient Nc/Nga
mice exhibit skin changes comparable
to those of STAT6-positive Nc/Nga
littermates, but undetectable IgE serum
levels, suggesting that AD-like skin
changes in Nc/Nga mice are IgE/Th2
independent (Yagi et al., 2002). The
DLN of the skin lesions in STAT6-
deficient Nc/Nga mice exhibited mas-
sive enlargement elicited by the accu-
mulation of activated IFN-g-secreting
T cells. Moreover, caspase I, IL-18,
IL-12, and IFN-g are found to be
highly expressed in skin lesions, with
simultaneous elevation of eotaxin 2
and CCR3 expression. Therefore, the
Th2-mediated immune response is not
necessary for the development of AD-
like skin disease in Nc/Nga mice. The
skin microenvironment that favored
IFN-g production in STAT6-deficient
Nc/Nga correlates with the skin disease
and infiltration of eosinophils, possibly
because IFN-g induces eotaxin 2 and
CCR3 expression. It is yet to be
observed whether the increased IFN-g
production in lesions of STAT6-defi-
cient Nc/Nga mice is driven by a defect
in the innate immunity of Nc/Nga
mice. In this regard, the IL-18 gene
is near the locus responsible for skin
disease in Nc/Nga mice on chromo-
some 9. It is possible that a non-
immune reaction with increased
caspase 1, IL-18, and IL-12 expression
in the skin microenvironment may
result in increased IFN-g production,
leading to the induction of eotaxin 2
expression that acts as a chemoattrac-
tant for CCR3-expressing eosinophils.
Therefore, the IFN-g-favored skin
microenvironment is likely the cause
of pathology in these mice. Generation
of Rag2-, caspase 1-, IL-18-, and IFN-g-
deficient Nc/Nga mice is needed to
answer these questions.
Nc/Nga mice show skin barrier
abnormalities with increased transepi-
dermal water loss and abnormal skin
conductivity under conventional con-
ditions, and impaired ceramide meta-
bolism, all of which might predispose
these mice to the development of
dermatitis (Aioi et al., 2001).
Other mouse strains with spontaneous
dermatitis. Other stains of mice that
spontaneously develop dermatitis have
been proposed as possible models of
allergic dermatitis. Naruto Research
Institute Otsuka (NOA) mice exhibit
hair loss and pruritic ulcerative derma-
titis with mast cell accumulation in the
dermis, and high serum levels of IgE;
however, they lack classical histo-
logical characteristics of human AD
(Watanabe et al., 1999). DS-Ng mice,
another inbred strain that was estab-
lished 20 years ago, have been reported
to develop spontaneous dermatitis
only under conventional conditions.
The severity of the dermatitis correlated
with the total IgE serum levels (Hikita
et al., 2002). Interestingly, heavy
colonization of S. aureus was found in
skin lesions. Moreover, skin application
of heat-killed S. aureus to DS-Nh mice
induced similar dermatitis. Therefore,
these mice could be a good model
for S. aureus-associated AD (Haraguchi
et al., 1997).
Conclusion
Mouse models of AD have shed im-
portant light into the pathogenesis of
allergic skin inflammation. They have
highlighted the role of mechanical
injury and of skin barrier disruption in
allergic sensitization to epicutaneously
introduced allergens. More impor-
tantly, they allow an in-depth dissec-
tion of the mediators and cells that are
critical for the development of the
allergic response to EC sensitization.
A better insight into the mechanisms
of the elicitation and effector phases of
EC sensitization is made possible by
these models and will ultimately lead
to a wider array of therapeutic inter-
ventions in this common and poten-
tially debilitating disease.
There is strong evidence that a
genetically defective skin barrier func-
tion is an important predisposing factor
for AD, as illustrated by the observa-
tion that B15% of AD patients have a
defective filaggrin gene. Mice that
have a genetic defect in barrier func-
tion will most likely provide a model of
AD closer to the human disease than
models provided by EC sensitization
of WT mice with allergens or haptens
or by transgenic overexpression of
cytokines in the skin or disruption of
immune genes and will have an
advantage over Nc/Nga mice in which
the genetic defect is not known. On
the basis of observations that barrier
disruption by skin injury in WT mice
results in Th2-dominated skin inflam-
mation and on the observation that
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chronic inflammation in normal mouse
skin repeatedly sensitized with hapten
disrupts barrier function, we predict
that mice with genetically defective
barrier function, for example, filag-
grin-deficient mice, will be highly
sensitive to the development of Th2-
skewed skin inflammation in response
to environmental antigens and that this
inflammation will further exacerbate
the skin barrier defect and result in
the downregulation of the expression of
antimicrobial genes in the skin and
predisposition to bacterial growth and
superinfection, all features of human
AD. There is little doubt that the
generation of mice deficient in filaggrin
and other epidermal genes that are
important for intact skin barrier func-
tion is forthcoming. Application of the
knowledge gained from existing mouse
models of AD to mice with genetic
defects in skin barrier function should
provide AD models that closely mimic
human disease.
ACKNOWLEDGMENTS
This work was supported by NIH Grant AR-
047417 to RSG and AHA Fellowship Grant
0625838T to HJ.
REFERENCES
Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR,
Ogawa H et al. (2001) Impairment of skin
barrier function in NC/Nga Tnd mice as a
possible model for atopic dermatitis. Br J
Dermatol 144:12–8
Alenius H, Laouini D, Woodward A, Mizoguchi
E, Bhan AK, Castigli E et al. (2002) Mast cells
regulate IFN-gamma expression in the skin
and circulating IgE levels in allergen-induced
skin inflammation. J Allergy Clin Immunol
109:106–13
Barton D, HogenEsch H, Weih F (2000) Mice
lacking the transcription factor RelB develop
T cell-dependent skin lesions similar to
human atopic dermatitis. Eur J Immunol
30:2323–32
Chan LS, Robinson N, Xu L (2001) Expression of
interleukin-4 in the epidermis of transgenic
mice results in a pruritic inflammatory skin
disease: an experimental animal model to
study atopic dermatitis. J Invest Dermatol
117:977–83
Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh
B, Stumhofer JS, McClanahan T et al. (2006)
Anti-IL-23 therapy inhibits multiple inflam-
matory pathways and ameliorates autoim-
mune encephalomyelitis. J Clin Invest
116:1317–26
Dillon SR, Sprecher C, Hammond A, Bilsborough
J, Rosenfeld-Franklin M, Presnell SR et al.
(2004) Interleukin 31, a cytokine produced
by activated T cells, induces dermatitis in
mice. Nat Immunol 5:752–60
Ekholm E, Egelrud T (1999) Stratum corneum
chymotryptic enzyme in psoriasis. Arch
Dermatol Res 291:195–200
ElKhal A, Pichavant M, He R, Scott J, Meyer E,
Goya S et al. (2006) CD1d restricted natural
killer T (NKT) cells are not required for
allergic skin inflammation in a murine model
of atopic dermatitis. J All Clin Immunol
118:1363–8
Fartasch M (1997) Epidermal barrier in disorders
of the skin. Microsc Res Tech 38:361–72
Geha RS (2003) Allergy and hypersensitivity—
nature versus nurture in allergy and hyper-
sensitivity—editorial overview. Curr Opin
Immunol 15:603–8
Hansson L, Backman A, Ny A, Edlund M, Ekholm
E, Ekstrand Hammarstrom B et al. (2002)
Epidermal overexpression of stratum cor-
neum chymotryptic enzyme in mice: a
model for chronic itchy dermatitis. J Invest
Dermatol 118:444–9
Haraguchi M, Hino M, Tanaka H, Maru M (1997)
Naturally occurring dermatitis associated
with Staphylococcus aureus in DS-Nh mice.
Exp Anim 46:225–9
He R, Oyoshi MK, Jin H, Geha RS (2007)
Epicutaneous antigen exposure induces a
Th17 response that drives airway inflamma-
tion after inhalation challenge. Proc Natl
Acad Sci USA 104:15817–22
Hikita I, Yoshioka T, Mizoguchi T, Tsukahara K,
Tsuru K, Nagai H et al. (2002) Characteriza-
tion of dermatitis arising spontaneously in
DS-Nh mice maintained under conventional
conditions: another possible model for ato-
pic dermatitis. J Dermatol Sci 30:142–53
Homey B, Alenius H, Muller A, Soto H, Bowman
EP, Yuan W et al. (2002) CCL27–CCR10
interactions regulate T cell-mediated skin
inflammation. Nat Med 8:157–65
Homey B, Steinhoff M, Ruzicka T, Leung DY
(2006) Cytokines and chemokines orches-
trate atopic skin inflammation. J Allergy Clin
Immunol 118:178–89
Howell MD, Jones JF, Kisich KO, Streib JE, Gallo
RL, Leung DY (2004) Selective killing of
vaccinia virus by LL-37: implications for
eczema vaccinatum. J Immunol 172:1763–7
Huang CH, Kuo IC, Xu H, Lee YS, Chua KY (2003)
Mite allergen induces allergic dermatitis with
concomitant neurogenic inflammation in
mouse. J Invest Dermatol 121:289–93
Jong MC, Gijbels MJ, Dahlmans VE, Gorp PJ,
Koopman SJ, Ponec M et al. (1998) Hyper-
lipidemia and cutaneous abnormalities in
transgenic mice overexpressing human apo-
lipoprotein C1. J Clin Invest 101:145–52
Kawamoto S, Yalcindag A, Laouini D, Brodeur S,
Bryce P, Lu B et al. (2004) The anaphylatoxin
C3a downregulates the Th2 response to
epicutaneously introduced antigen. J Clin
Invest 114:399–407
Kim E, Lee JE, Namkung JH, Park JH, Kim S, Shin
ES et al. (2007) Association of the single-
nucleotide polymorphism and haplotype of
the interleukin 18 gene with atopic derma-
titis in Koreans. Clin Exp Allergy 37:865–71
Kimura M, Tsuruta S, Yoshida T (1998) Correla-
tion of house dust mite-specific lymphocyte
proliferation with IL-5 production, eosino-
philia, and the severity of symptoms in
infants with atopic dermatitis. J Allergy Clin
Immunol 101:84–9
Kohara Y, Tanabe K, Matsuoka K, Kanda N,
Matsuda H, Karasuyama H et al. (2001) A
major determinant quantitative-trait locus
responsible for atopic dermatitis-like skin
lesions in NC/Nga mice is located on
Chromosome 9. Immunogenetics 53:15–21
Konishi H, Tsutsui H, Murakami T, Yumikura-
Futatsugi S, Yamanaka K, Tanaka M et al.
(2002) IL-18 contributes to the spontaneous
development of atopic dermatitis-like
inflammatory skin lesion independently
of IgE/stat6 under specific pathogen-free
conditions. Proc Natl Acad Sci USA 99:
11340–5
Langrish CL, Chen Y, Blumenschein WM, Mattson
J, Basham B, Sedgwick JD et al. (2005) IL-23
drives a pathogenic T cell population that
induces autoimmune inflammation. J Exp
Med 201:233–40
Laouini D, Alenius H, Bryce P, Oettgen H,
Tsitsikov E, Geha RS (2003a) IL-10 is critical
for Th2 responses in a murine model of
allergic dermatitis. J Clin Invest 112:1058–66
Laouini D, Elkhal A, Yalcindag A, Kawamoto S,
Oettgen H, Geha RS (2005) COX-2 inhibi-
tion enhances the TH2 immune response to
epicutaneous sensitization. J Allergy Clin
Immunol 116:390–6
Laouini D, Kawamoto S, Yalcindag A, Bryce P,
Mizoguchi E, Oettgen H et al. (2003b)
Epicutaneous sensitization with superantigen
induces allergic skin inflammation. J Allergy
Clin Immunol 112:981–7
Leung DYM, Bieber T (2003) Atopic dermatitis.
Lancet 361:151–60
Leung DYM, Boguniewicz M, Howell MD,
Nomura I, Hamid OA (2004) New insights
into atopic dermatitis. J Clin Invest 113:
651–7
Li XM, Kleiner G, Huang CK, Lee SY, Schofield B,
Soter NA et al. (2001) Murine model of
atopic dermatitis associated with food hy-
persensitivity. J Allergy Clin Immunol 107:
693–702
Liu YJ (2007) Thymic stromal lymphopoietin and
OX40 ligand pathway in the initiation of
dendritic cell-mediated allergic inflamma-
tion. J Allergy Clin Immunol 120:238–44;
quiz 245–236
Ma W, Bryce P, Humbles AA, Laouini D,
Yalcindag A, Alenius H et al. (2002) CCR3
is essential for skin eosinophilia and airway
hyperresponsiveness in a murine model
of allergic skin inflammation. J Clin Invest
109:621–8
Man MQ, Hatano Y, Lee SH, Man M, Chang S,
Feingold KR et al. (2008) Characterization of
a hapten-induced, murine model with multi-
ple features of atopic dermatitis: structural,
immunologic, and biochemical changes
www.jidonline.org 39
H Jin et al.
Animal Models of Atopic Dermatitis
following single versus multiple oxazolone
challenges. J Invest Dermatol 128:79–86
Matsuda H, Watanabe N, Geba GP, Sperl J,
Tsudzuki M, Hiroi J et al. (1997) Develop-
ment of atopic dermatitis-like skin lesion
with IgE hyperproduction in NC/Nga mice.
Int Immunol 9:461–6
Matsumoto K, Mizukoshi K, Oyobikawa M,
Ohshima H, Tagami H (2004) Establishment
of an atopic dermatitis-like skin model in a
hairless mouse by repeated elicitation of
contact hypersensitivity that enables to con-
duct functional analyses of the stratum
corneum with various non-invasive bio-
physical instruments. Skin Res Technol 10:
122–9
Matsumoto M, Ra C, Kawamoto K, Sato H, Itakura
A, Sawada J et al. (1999) IgE hyperproduc-
tion through enhanced tyrosine phos-
phorylation of Janus kinase 3 in NC/Nga
mice, a model for human atopic dermatitis.
J Immunol 162:1056–63
Milgrom H (2002) Attainments in atop: special
aspects of allergy and IgE. Adv Pediatr 49:
273–97
Mitchell EB, Crow J, Chapman MD, Jouhal S,
Pope FM, Platts-Mill TAE (1982) Basophils in
allergen-induced patch test sites in atopic
dermatitis. Lancet 1:127–30
Morar N, Cookson WO, Harper JI, Moffatt MF
(2007) Filaggrin mutations in children with
severe atopic dermatitis. J Invest Dermatol
127:1667–72
Nagelkerken L, Verzaal P, Lagerweij T, Persoon-
Deen C, Berbee JF, Prens EP et al. (2007)
Development of atopic dermatitis in mice
transgenic for human apolipoprotein C1.
J Invest Dermatol 128:1165–72
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H
(2001) Interleukin-18 regulates both Th1 and
Th2 responses. Annu Rev Immunol 19:
423–74
Nomura T, Sandilands A, Akiyama M, Liao H,
Evans AT, Sakai K et al. (2007) Unique
mutations in the filaggrin gene in Japanese
patients with ichthyosis vulgaris and atopic
dermatitis. J Allergy Clin Immunol 119:
434–40
Novak N, Bieber T (2005) The role of dendritic cell
subtypes in the pathophysiology of atopic
dermatitis. J Am Acad Dermatol 53:S171–6
Novak N, Bieber T, Kraft S (2004) Immunoglobu-
lin E-bearing antigen-presenting cells in
atopic dermatitis. Curr Allergy Asthma Rep
4:263–9
Novak N, Bieber T, Leung DY (2003) Immune
mechanisms leading to atopic dermatitis.
J Allergy Clin Immunol 112:S128–39
Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry
G, Fathman CG et al. (2002) CD4 T-helper
cells engineered to produce IL-10 prevent
allergen-induced airway hyperreactivity and
inflammation. J Allergy Clin Immunol 110:
460–8
Okamura H, Tsutsi H, Komatsu T, Yutsudo M,
Hakura A, Tanimoto T et al. (1995) Cloning
of a new cytokine that induces IFN-gamma
production by T cells. Nature 378:88–91
Palmer CN, Irvine AD, Terron-Kwiatkowski A,
Zhao Y, Liao H, Lee SP et al. (2006)
Common loss-of-function variants of the
epidermal barrier protein filaggrin are a
major predisposing factor for atopic derma-
titis. Nat Genet 38:441–6
Pastore S, FanalesBelasio E, Albanesi C, Chinni
LM, Giannetti A, Girolomoni G (1997)
Granulocyte macrophage colony-stimulating
factor is overproduced by keratinocytes in
atopic dermatitis: implications for sustained
dendritic cell activation in the skin. J Clin
Invest 99:3009–17
Sampson H, McCaskill C (1985) Food hypersen-
sitivity and atopic dermatitis: evaluation of
113 patients. J Pediatr 107:669–75
Soumelis V, Reche PA, Kanzler H, Yuan W,
Edward G, Homey B et al. (2002) Human
epithelial cells trigger dendritic cell medi-
ated allergic inflammation by producing
TSLP. Nat Immunol 3:673–80
Spergel J, Mizoguchi E, Brewer J, Martin T, Bhan
A, Geha R (1998) Epicutaneous sensitization
with protein antigen induces localized aller-
gic dermatitis and hyperresponsiveness to
metacholine after single exposure to aero-
solized antigen in mice. J Clin Invest 101:
1614–22
Spergel JM, Mizoguchi E, Oettgen H, Bhan AK,
Geha RS (1999) Roles of TH1 and TH2
cytokines in a murine model of allergic
dermatitis. J Clin Invest 103:1103–11
Spergel JM, Paller AS (2003) Atopic dermatitis and
the atopic march. J Allergy Clin Immunol
112:S118–27
Trautmann A, Akdis M, Kleemann D, Altznauer F,
Simon HU, Graeve T et al. (2000) T cell-
mediated Fas-induced keratinocyte apopto-
sis plays a key pathogenetic role in eczema-
tous dermatitis. J Clin Invest 106:25–35
Tsukuba T, Okamoto K, Okamoto Y, Yanagawa
M, Kohmura K, Yasuda Y et al. (2003)
Association of cathepsin E deficiency with
development of atopic dermatitis. J Biochem
(Tokyo) 134:893–902
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM,
Stockinger B (2006) TGFbeta in the context
of an inflammatory cytokine milieu supports
de novo differentiation of IL-17-producing
T cells. Immunity 24:179–89
Vestergaard C, Yoneyama H, Murai M, Nakamura
K, Tamaki K, Terashima Y et al. (1999)
Overproduction of Th2-specific chemokines
in NC/Nga mice exhibiting atopic dermatitis-
like lesions. J Clin Invest 104:1097–105
Watanabe O, Natori K, Tamari M, Shiomoto Y,
Kubo S, Nakamura Y (1999) Significantly
elevated expression of PF4 (platelet factor 4)
and eotaxin in the NOA mouse, a model for
atopic dermatitis. J Hum Genet 44:173–6
Weih F, Warr G, Yang H, Bravo R (1997)
Multifocal defects in immune responses in
RelB-deficient mice. J Immunol 158:5211–8
Woodward AL, Spergel JM, Alenius H, Mizoguchi
E, Bhan AK, Castigli E et al. (2001) An
obligate role for T-cell receptor alphabeta+
T cells but not T-cell receptor gammadelta+
T cells, B cells, or CD40/CD40L interactions
in a mouse model of atopic dermatitis.
J Allergy Clin Immunol 107:359–66
Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo
M (2002) Development of atopic dermatitis-
like skin lesions in STAT6-deficient NC/Nga
mice. J Immunol 168:2020–7
Yalcindag A, He R, Laouini D, Alenius H, Carroll
M, Oettgen HC et al. (2006) The comple-
ment component C3 plays a critical role in
both T(H)1 and T(H)2 responses to antigen.
J Allergy Clin Immunol 117:1455–61
Yamanaka K, Tanaka M, Tsutsui H, Kupper TS,
Asahi K, Okamura H et al. (2000) Skin-
specific caspase-1-transgenic mice show
cutaneous apoptosis and pre-endotoxin
shock condition with a high serum level of
IL-18. J Immunol 165:997–1003
Yoo J, Omori M, Gyarmati D, Zhou B, Aye T,
Brewer A et al. (2005) Spontaneous
atopic dermatitis in mice expressing an
inducible thymic stromal lymphopoietin
transgene specifically in the skin. J Exp
Med 202:541–9
40 Journal of Investigative Dermatology (2009), Volume 129
H Jin et al.
Animal Models of Atopic Dermatitis
